Press releases
- Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
- Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
- Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
- Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
- Edwards Lifesciences Reports Fourth Quarter Results
- Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve
- Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024
More ▼
Key statistics
As of last trade Edwards Lifesciences Corp (EWL:DUS) traded at 80.34, -9.06% below its 52-week high of 88.34, set on Mar 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 80.32 |
---|---|
High | 80.42 |
Low | 80.32 |
Bid | 80.74 |
Offer | 81.56 |
Previous close | 80.74 |
Average volume | 173.00 |
---|---|
Shares outstanding | 601.93m |
Free float | 596.57m |
P/E (TTM) | 37.56 |
Market cap | 52.04bn USD |
EPS (TTM) | 2.30 USD |
Data delayed at least 15 minutes, as of Apr 19 2024 11:31 BST.
More ▼